Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Diagnosis and Management of Opioid-Induced Bowel Dysfunction in Patients With Advanced Cancer

Amanda Fredericks
Genevieve Hollis
Carrie Tompkins Stricker
CJON 2010, 14(6), 701-704 DOI: 10.1188/10.CJON.701-704

Opioid-induced bowel dysfunction (OBD) is characterized by a constellation of symptoms, including constipation; dry, hard stools; straining; and incomplete evacuation. The use of a prophylactic bowel regimen that includes a stimulant laxative and stool softener generally is accepted and should be initiated at the start of opioid therapy. Effective prevention and treatment of OBD reduce the risk of associated physiologic complications and can improve pain management and quality of life for patients and their families.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or